Moderna COVID-19 Vaccine (2023-2024 Formulation) Fact Sheet

Moderna COVID-19 Vaccine (2023-2024 Formulation) is a vaccine for the prevention of COVID-19 in individuals 6 months through 11 years of age.


Moderna COVID-19 Vaccine (2023-2024 Formulation) Fact Sheet - cover page
Brand
Moderna
Category
Drugs
Document type
Product Leaflet
Language
Chinese
Pages
6
File format
PDF
File size
306 KB
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
BF3D40FC1693E991216D3A58316F2CD9

About this manual

The Moderna COVID-19 Vaccine (2023-2024 Formulation) is an mRNA vaccine encoding the spike protein of the Omicron XBB.1.5 variant. It is authorized for emergency use to prevent COVID-19 in individuals 6 months through 11 years of age. The document explains the vaccine's benefits, risks, administration schedule, contraindications, ingredients, and potential side effects including rare cases of myocarditis and pericarditis. This manual is written in Chinese.

Frequently asked questions

Who should not get the Moderna COVID-19 Vaccine?

Individuals who had a severe allergic reaction after a previous dose of any Moderna COVID-19 vaccine or to any ingredient of the vaccine should not get it.

Can the vaccine cause COVID-19?

No, the vaccine does not contain SARS-CoV-2 virus and cannot cause COVID-19 infection.

Download PDF (306 KB)

More Moderna Manuals


View all Moderna manuals →